KRO trades 9.6% below Wall Street's consensus target of $7.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes KRO achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Kronos Worldwide, Inc. (KRO) has a Wall Street consensus price target of $7.50, based on estimates from 7 covering analysts. With the stock currently trading at $6.84, this represents a potential upside of +9.6%. The company has a market capitalization of $787M.
Analyst price targets range from a low of $5.00 to a high of $10.00, representing a 67% spread in expectations. The median target of $7.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, KRO trades at a trailing P/E of -7.1x. Analysts expect EPS to grow +94.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
TROXTronox Holdings plc | $1.2B | $7.40 | $8.33 | +12.6% | Buy | — | 17 |
VHIValhi, Inc. | $383M | $13.53 | — | — | Sell | 3.9x | 1 |
HUNHuntsman Corporation | $2.1B | $12.07 | $13.80 | +14.3% | Hold | — | 33 |
CCThe Chemours Company | $3.3B | $21.77 | $25.75 | +18.3% | Hold | 15.5x | 20 |
EMNEastman Chemical Company | $8.3B | $72.49 | $79.89 | +10.2% | Buy | 11.4x | 35 |
RPMRPM International Inc. | $13.8B | $108.00 | $124.67 | +15.4% | Buy | 19.7x | 22 |
SHWThe Sherwin-Williams Company | $79.1B | $320.79 | $374.56 | +16.8% | Buy | 27.4x | 38 |
PPGPPG Industries, Inc. | $26.5B | $118.21 | $128.50 | +8.7% | Buy | 15.0x | 38 |
IFFInternational Flavors & Fragrances Inc. | $19.6B | $76.72 | $88.13 | +14.9% | Buy | 17.3x | 33 |
NEMNewmont Corporation | $115.0B | $103.79 | $143.33 | +38.1% | Buy | 10.1x | 36 |
Quick answers to the most common questions about buying KRO stock.
The consensus price target for KRO is $7.5, close to the current price of $6.84 (9.6% implied move). Based on 7 analyst estimates, the stock appears fairly valued near current levels.
KRO has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $7.5 implies 9.6% upside from current levels.
KRO's current price is $6.84 with a consensus target of $7.5 (9.6% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $10 for KRO, while the most conservative target is $5. The consensus of $7.5 represents the median expectation. These targets typically reflect 12-month expectations.
KRO is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KRO stock forecast based on 7 Wall Street analysts shows a consensus price target of $7.5, with estimates ranging from $5 (bear case) to $10 (bull case). The median consensus rating is "Hold".
KRO appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $7.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KRO analyst price targets range from $5 to $10, a 67% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.